Angiotensin blockade and matrix synthesis by glomerular epithelial cells in high glucose: A further experimental insight into the pathophysiology of diabetic nephropathy

Clinica Terapeutica

Volumn 159, Issue 3, 2008, Pages 151-154

  Morano, Susanna ^a,b   Cipriani, R ^a   Santangelo, C ^a   Fallarino, M ^a   Carnovale, A ^a   Mandosi, E ^a   Gatti, A ^a   Sensi, M ^a   Di Mario, U ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Angiotensin converting enzyme inhibitor; Angiotensin II receptor 1 antagonist; Diabetic nephropathy; Extracellular matrix; Glomerular epithelial cells

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; FIBRONECTIN; GLUCOSE; LAMININ; LOSARTAN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DIABETIC NEPHROPATHY; DRUG EFFECT; EVALUATION; EXTRACELLULAR MATRIX; GLOMERULUS EPITHELIUM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEINURIA;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CELLS, CULTURED; DIABETIC NEPHROPATHIES; ENALAPRILAT; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FIBRONECTINS; HYPERGLYCEMIA; KIDNEY GLOMERULUS; LAMININ; LOSARTAN; MICE; RNA, MESSENGER;

EID: 47549097572     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Levidiotis V, Power DA. New insights into the molecular biology of the glomerular filtration barrier and associated disease. Nephrology 2005; 10:157-66
2. Kim TS, Kim JY, Hong HK, et al. mRNA expression of glomerular basement membrane proteins and TGF-beta1 in human membranous nephropathy. J. Pathol 1999; 189:425-30
3. St John PL, Abrahamson DR. Glomerular endothelial cells and podocytes jointly synthesize laminin-1 and -11 chains. Kidney Int 2001; 60:1037-46
4. Effie CT. Microvascular basement membranes in diabetes mellitus. J Pathol 2003; 200:537-46
5. Raptis AE, Viberti G. Pathogenesis of diabetic nephropathy. Exp Clin Endocrinol Diabetes 2001; 109:S424-37
6. Ikehara K, Tada H, Kuboki K, et al. Role of protein kinase C-angiotensin II pathway for extracellular matrix production in cultured human mesangial cells exposed to high glucose levels. Diabetes Res Clin Pract 2003; 59:25-30
7. Leehey DJ, Singh AK, Alavi N, et al. Role of angiotensin II in diabetic nephropathy. Kidney Int 2000; 77:S93-8
8. Weber KT, Swamynathan SK, Guntaka RV, et al. Angiotensin II and extracellular matrix homeostasis. Int J Biochem Cell Bio 1999; 31:395-403
9. Lai KN, Leung JCK, Lai KB, et al. Gene expression of the renin-angiotensin system in human kidney. J Hypertens 1998; 16:91-102
10. Song JH, Cha SH, Hong SB, et al. Dual blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease. J Hypertens 2006; 24:S101-6
11. Strippoli GF, Craig MC, Schena FP, et al. Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression. J Am Soc Nephrol 2006; 17:S153-5
12. Andersen S, Tarnow L, Rossing P, et al. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int 2000; 57:601-6
13. Kedziora-Kornatowska K. Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic rats. Clin Chim Acta 1999; 287:19-27
14. Kuriyama S, Tomonari H, Abe A, et al. Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy. Nephron 2000; 86:529-30
15. Sica DA, Bakris GL. Type 2 diabetes: RENAAL and IDNT-the emergence of new treatment options. J. Clin. Hypertens. 2002; 4:52-7
16. Cooper ME, Cao Z, Rumble JR, et al. Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: morphological and molecular biological studies. Metabolism 1998; 47:24-7
17. Lapinski R, Perico N, Remuzzi A, et al. Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. J. Am. Soc. Nephrol 1996; 7:653-60
18. Andreoli SP. Captopril scavenges hydrogen peroxide and reduces, but does not eliminate, oxidant-induced cell injury. Am J Physiol 1993; 264:F120-7
19. Guh JY, Yang ML, Yang YL, et al. Captopril reverses high glucose induced growth effects on LLC-PK cells partly by decreasing tranforming growth factor-beta receptor protein expressions. J Am Soc Nephrol 1996; 7:1207-15
20. MacKay K, Striker LJ, Stauffer JW, et al. Transforming growth factor beta. Murine glomerular receptors and responses of isolated glomerular cells. J. Clin. Invest 1989; 83:1160-7
21. Conti FG, Elliot SJ, Striker LJ, et al. Binding of insulin-like growth factor-I by glomerular endohelial and epthelil cells: further evidence for IGF-I action in the renal glomerulus. Biochem Biophysical Res Com 1989; 163:952-58
22. Stow JL, Soroka CJ, MacKay K, et al. Basement membrane heparansulphate proteoglycan is the main proteoglycan synthesized by glomerular epithelial cells in culture. Am J Pathol 1989; 135:637-46
23. Conti FG, Striker LJ, Elliot SJ, et al. Synthesis and release of insulinlike growth factor I by mesangial cells in culture. Am J Physiol 1988; 255:F1214-9
24. Liebau MC, Lang D, Bohm J, et al.. Functional expression of the renin-angiotensin system in human podocytes. Am J Physio. Renal Physiol 2006; 290:F710-9
25. Konoshita T, Wakahara S, Mizuno S, et al. Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. Diabetes Care 2006; 29:848-55
26. Sharma M, Sharma R, Greene AS, et al. Documentation of angiotensin II receptors in glomerular epithelial cells. Am J Physiol 1998; 274:F623-7
27. Ding G, Reddy K, Kapasi AA, et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal. Physiol 2002; 283:F173-80
28. Morano S, Guidobaldi L, Cipriani R, et al. High glucose modifies heparansulphate synthesis by mouse glomerular epithelial cells. Diab Metab Rev Res 1999; 15:13-20